GOAL.MD vs Noom
GOAL.MD and Noom both sell semaglutide and tirzepatide; this is how their prices, coverage and records differ.
Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more
If you are choosing between GOAL.MD and Noom, price alone will not settle it. Both prescribe semaglutide and tirzepatide, so moving from one to the other would not change your drug. GOAL.MD leads our six-part score, 7.8 to 6.9.
GOAL.MD vs Noom price
GOAL.MD and Noom start at the same figure, $179 a month, so the entry price does not separate them. Look at what each price covers and at the per-drug prices below.
Drug by drug: Semaglutide costs the same at both, $179 a month; tirzepatide is cheaper at GOAL.MD ($249 a month vs $349 a month).
Medications and formats
Both sell semaglutide and tirzepatide.
On format they match: each offers compounded injections and brand-name pens.
Where each one treats patients
GOAL.MD lists 50 states, and Noom does not publish where it ships.
Pricing
GOAL.MD
Personalized (compounded) tirzepatide from $249/mo new-patient first month; brand Zepbound from $394/mo
Noom
The first 3 weeks of the program with 4 weeks of medication start from $149, then $349 per month plus tax on a 12-week subscription. The program also offers generic liraglutide.
The first 3 weeks with 4 weeks of medication start from $79, then $179 per month plus tax on a 12-week subscription. Compounded tirzepatide is also offered on this plan.
What each price covers
Both prices cover the clinician visit and coaching.
GOAL.MD's price also covers the medication itself and shipping, which Noom does not claim.
GOAL.MD is silent on lab work.
Noom is silent on the medication itself, shipping and lab work.
That matters most for the drug: unless Noom confirms otherwise, budget for medication on top of its listed price.
GOAL.MD
Covered by the monthly price
Medication
In the price
Clinician visits
In the price
Shipping
In the price
Lab work
Not stated
Coaching
In the price
Noom
Covered by the monthly price
Medication
Not stated
Clinician visits
In the price
Shipping
Not stated
Lab work
Not stated
Coaching
In the price
Where each one scores higher
Overall, GOAL.MD scores 7.8 and Noom 6.9 out of 10.
GOAL.MD is stronger on accessibility (10.0 vs 5.0) and support (8.5 vs 4.0).
Value, effectiveness, user experience and trust & safety are within half a point.
GOAL.MD
7.8/10
Noom
6.9/10
Value25%
Effectiveness25%
User Experience15%
Trust & Safety15%
Accessibility10%
Support10%
FDA warning letters
Neither GOAL.MD nor Noom has an FDA warning letter on record with us.
Features & Coverage
| Feature | GOAL.MD | Noom |
|---|---|---|
| Starting Price | $179/mo | $179/mo |
| Features | ✓8 features | 2 features |
| States Available | 50 | Not disclosed |
| Compounded | ✓ Yes | ✓ Yes |
| Brand Name | ✓ Yes | ✓ Yes |
| FSA/HSA Accepted | — | — |
| FDA Warning Letters | None | None |
About GOAL.MD
GOAL.MD is a St. Louis-based telehealth platform. Compounded semaglutide starts at $179/mo, brand Ozempic and Wegovy from $294/mo, and Zepbound from $394/mo, with brand pen pricing published by dose tier and offered as a bridge to the brand drugs. Renewals are manual with no auto-billing, and a nutrition coach is included free.
Read our full GOAL.MD review →About Noom
Noom is a behavioral weight loss app. It also prescribes GLP-1 medications through Noom Med.
Read our full Noom review →Pros & Cons
GOAL.MD
What we like
- Semaglutide costs $179 a month, close to the $185 median for compounded semaglutide across the sellers we compare
- Tirzepatide costs $394 a month, 68% below the $1249 median for brand-name tirzepatide across the sellers we compare
- Shows its price before the medical questionnaire, so you can compare it without handing over health information
- The monthly price stays the same as your dose goes up
- The monthly price includes the medication, clinician visits, shipping and coaching
- Serves all 50 states
- We found no FDA warning letters issued to GOAL.MD
Watch-outs
- Ask which pharmacy fills the prescription before you pay, so you can check its license
- Its semaglutide and tirzepatide are compounded rather than FDA-approved, so they have not been reviewed by the agency for safety, effectiveness or manufacturing quality
Noom
What we like
- Semaglutide costs $179 a month, close to the $185 median for compounded semaglutide across the sellers we compare
- Tirzepatide costs $349 a month, 72% below the $1249 median for brand-name tirzepatide across the sellers we compare
- Shows its price before the medical questionnaire, so you can compare it without handing over health information
- The monthly price includes clinician visits and coaching
- We found no FDA warning letters issued to Noom
Watch-outs
- Confirm it serves your state before you start the intake
- Ask which pharmacy fills the prescription before you pay, so you can check its license
- Its semaglutide is compounded rather than FDA-approved, so it has not been reviewed by the agency for safety, effectiveness or manufacturing quality
Our Verdict
GOAL.MD wins this one, 7.8 to 6.9, above all for starting below a standard dose, with microdose tiers. Noom fits better if coaching bundled into the price rather than sold separately is your priority.
Choose GOAL.MD if…
You want starting below a standard dose, with microdose tiers and an opening price near $179 a month.
Choose Noom if…
You want coaching bundled into the price rather than sold separately and an opening price near $179 a month.
Ready to start? GLP-1 providers we have vetted
Telehealth providers, vetted by us, prescribing GLP-1 online.
Vetted by our editors · no insurance required
Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more
RxSpan MD
Knowing which pharmacy fills the vial: it names Belmar Pharmacy
From $249/mo
Get started →Luvo Health
Moving between compounded and brand without changing seller
From $249/mo
Get started →Strut Health
Semaglutide at $99/month, 48% below the typical price
From $99/mo
Get started →GOAL.MD vs Noom: FAQ
Close alternatives to GOAL.MD and Noom
- GOAL.MD vs Vaylen
- GOAL.MD vs DudeMeds
- GOAL.MD vs Healthicare
- Noom vs Vaylen
- Noom vs DudeMeds
- Noom vs Healthicare
Or see the full category ranking.
Novo Nordisk A/S owns the Wegovy®, Ozempic® and Rybelsus® marks; Eli Lilly and Company owns Mounjaro® and Zepbound®. Every other product name and mark on this page belongs to whoever owns it. No pharmaceutical manufacturer is affiliated with GLP Watchdog. See trademark disclaimer.